Serum fibroblast growth factor 21 levels are inversely associated with growth rates in infancy

Hormone Research in Paediatrics

Volumn 82, Issue 5, 2014, Pages 324-331

  Mericq, Verónica ^a   De Luca, Francesco ^d   Hernandez, Maria I ^d   Peña, Veronica ^b   Rossel, Katherine ^b   Garcia, Mirna ^b   Avila, Alejandra ^a   Cavada, Gabriel ^c   Iñiguez, German ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

FGF21; Growth factors; Preterms

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; GLUCOSE; INSULIN; LEPTIN; FIBROBLAST GROWTH FACTOR;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY WEIGHT; CATCH UP GROWTH; CHILD GROWTH; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GESTATIONAL AGE; GROWTH REGULATION; HUMAN; INSULIN BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NEWBORN; PREMATURITY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SMALL FOR DATE INFANT; UMBILICAL CORD BLOOD; WEIGHT GAIN; BLOOD; CHILD DEVELOPMENT; CLINICAL TRIAL; FEMALE; FOLLOW UP; MALE; MULTICENTER STUDY;

BODY HEIGHT; CHILD DEVELOPMENT; FEMALE; FIBROBLAST GROWTH FACTORS; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE;

EID: 84912109442     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000367922     Document Type: Article

References (17)

1. Domouzoglou EM, Maratos-Flier E: Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis. Am J Clin Nutr 2011; 93: 901S-905S.
2. Kharitonenkov A, Larsen P: FGF21 reloaded: challenges of a rapidly growing field. Trends Endocrinol Metab 2011; 22: 81-86.
3. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA: Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab 2008; 8: 77-83.
4. Mraz M, Bartlova M, Lacinova Z, Michalsky D, Kasalicky M, Haluzikova D, Matoulek M, Dostalova I, Humenanska V, Haluzik M: Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin Endocrinol (Oxf) 2009; 71: 369- 375.
5. Fazeli PK, Misra M, Goldstein M, Miller KK, Klibanski A: Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab 2010; 95: 369-374.
6. Dostalova I, Kavalkova P, Haluzikova D, Lacinova Z, Mraz M, Papezova H, Haluzik M: Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J Clin Endocrinol Metab 2008; 93: 3627-3632.
7. Pittaluga E, Vernal P, Llanos A, Vega S, Henrriquez MT, Morgues M, Escobar M, Diaz A, Standen J, Moncada P, Arriagada M, Rodriguez L, Mericq V: Benefits of supplemented preterm formulas on insulin sensitivity and body composition after discharge from the neonatal intensive care unit. J Pediatr 2011; 159: 926-932. e922.
8. Juez G: Intrauterine growth curve for the appropriate diagnosis of intrauterine growth retardation (in Spanish). Rev Med Chil 1989; 117: 1311.
9. Pitaluga E, Vernal P, Mena P, Figueroa A, Henriquez MT, Toha D: Curva de crecimiento intrauterino para prematuros entre 23 a 36 semanas de edad gestacional (in Spanish). Rev Chil Pediatr 2002; 73: 135-141.
10. De Onis M, Garza C, Victora CG, Onyango AW, Frongillo EA, Martines J: The WHO multicentre growth reference study: planning, study design, and methodology. Food Nutr Bull 2004; 25:S15-S26.
11. Soto N, Bazaes RA, Pena V, Salazar T, Avila A, Iniguez G, Ong KK, Dunger DB, Mericq MV: Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational- age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 2003; 88: 3645-3650.
12. Kubicky RA, Wu S, Kharitonenkov A, De Luca F: Role of fibroblast growth factor 21 in undernutrition-related attenuation of growth in mice. Endocrinology 2012; 153: 2287-2295.
13. Wu S, Levenson A, Kharitonenkov A, De Luca F: Fibroblast growth factor 21 inhibits chondrocyte function and growth hormone action directly at the growth plate. J Biol Chem 2012; 287: 26060-26067.
14. Semba RD, Sun K, Egan JM, Crasto C, Carlson OD, Ferrucci L: Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: The Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2012; 97: 1375-1382.
15. Lee Y, Lim S, Hong ES, Kim JH, Moon MK, Chun EJ, Choi SI, Kim YB, Park YJ, Park KS, Jang HC, Choi SH: Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status. Clin Endocrinol (Oxf) 2014; 80: 57-64.
16. Kubicky RA, Wu S, Kharitonenkov A, De Luca F: Role of fibroblast growth factor 21 in undernutrition-related attenuation of growth in mice. Endocrinology 2012; 153: 2287-2295.
17. Cifuentes L, Valenzuela CY, Cruz-Coke R, Armanet L, Lyng C, Harb Z: Genetic characterization of the hospital population of Santiago, Chile (in Spanish). Rev Med Chil 1988; 116: 28-33.